BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 237 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2020. The put-call ratio across all filers is 1.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $55,881,000 | -24.2% | 635,302 | -16.3% | 0.58% | -21.1% |
| Q1 2021 | $73,768,000 | -48.2% | 758,691 | -40.3% | 0.73% | -35.7% |
| Q4 2020 | $142,490,000 | +12.6% | 1,270,529 | -6.9% | 1.13% | +18.3% |
| Q3 2020 | $126,501,000 | +18.8% | 1,364,631 | 0.0% | 0.96% | -1.5% |
| Q2 2020 | $106,441,000 | +12.8% | 1,364,631 | -15.4% | 0.97% | -23.5% |
| Q1 2020 | $94,345,000 | -21.7% | 1,613,294 | +7.2% | 1.27% | -15.3% |
| Q4 2019 | $120,533,000 | +9.5% | 1,504,599 | +0.4% | 1.50% | -0.8% |
| Q3 2019 | $110,096,000 | -22.1% | 1,498,516 | 0.0% | 1.51% | -52.1% |
| Q2 2019 | $141,355,000 | +17.8% | 1,498,516 | 0.0% | 3.16% | -5.4% |
| Q1 2019 | $119,956,000 | +55.5% | 1,498,516 | +4.7% | 3.34% | +4.4% |
| Q4 2018 | $77,142,000 | – | 1,430,949 | – | 3.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 423,012 | $41,129,000 | 7.43% |
| Eagle Health Investments LP | 133,163 | $12,947,000 | 5.08% |
| DAFNA Capital Management LLC | 207,911 | $20,215,000 | 4.80% |
| Casdin Capital, LLC | 1,550,000 | $150,707,000 | 4.49% |
| SIB LLC | 65,151 | $6,335,000 | 3.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 913,702 | $88,839,000 | 3.29% |
| Integral Health Asset Management, LLC | 117,500 | $11,425,000 | 3.26% |
| Rock Springs Capital Management LP | 746,732 | $72,605,000 | 1.58% |
| Avidity Partners Management LP | 546,000 | $53,088,000 | 1.47% |
| Zebra Capital Management LLC | 12,698 | $1,235,000 | 1.36% |